What is the appropriate lorazepam ordering and dosing for opioid withdrawal based on the Clinical Opioid Withdrawal Scale (COWS) assessment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lorazepam for Opioid Withdrawal: Not Recommended as Primary Treatment

Lorazepam should NOT be ordered as primary treatment for opioid withdrawal based on COWS assessment; instead, buprenorphine is the evidence-based first-line therapy for moderate-to-severe opioid withdrawal (COWS ≥8), with lorazepam reserved only as adjunctive symptomatic treatment for anxiety and muscle cramps. 1

Critical Clarification: You're Asking About the Wrong Drug

The evidence is clear that benzodiazepines like lorazepam are adjunctive, not primary treatment for opioid withdrawal. The 2020 ACEP Clinical Policy explicitly states that nonopioid treatments including benzodiazepines "may help reduce catecholamine release during withdrawal and help alleviate muscle cramps as well as anxiety," but they are not the mainstay of therapy 1.

Evidence-Based Treatment Algorithm for Opioid Withdrawal

Step 1: Confirm Adequate Time Since Last Opioid Use

  • Short-acting opioids (heroin, morphine IR): >12 hours
  • Extended-release formulations (OxyContin): >24 hours
  • Methadone maintenance: >72 hours 1

Step 2: Assess Withdrawal Severity Using COWS

For COWS <8 (Mild Withdrawal):

  • No buprenorphine indicated
  • Reassess patient and COWS in 1-2 hours
  • Symptomatic treatment only (this is where lorazepam might be used)

For COWS ≥8 (Moderate to Severe Withdrawal):

  • Give buprenorphine 4-8 mg sublingual based on severity
  • Reassess after 30-60 minutes
  • Target total dose of 16 mg sublingual for most patients 1

If You Must Use Lorazepam: Dosing Guidelines

When used as adjunctive therapy only for anxiety and muscle cramps in opioid withdrawal:

Standard dosing from FDA labeling:

  • Initial: 2-3 mg/day divided into 2-3 doses
  • Range: 1-10 mg/day, with largest dose at bedtime
  • Elderly/debilitated: Start 1-2 mg/day divided 2

Critical Safety Warning: The FDA explicitly warns that concomitant use of benzodiazepines and opioids increases risk of drug-related mortality 2. If prescribing lorazepam with any opioid therapy:

  • Use lowest effective doses
  • Use minimum durations
  • Monitor closely for respiratory depression and sedation 2

Why Buprenorphine is Superior

The evidence strongly favors buprenorphine over symptomatic management alone:

  • More effective than α2-agonists (clonidine/lofexidine) at reducing withdrawal severity
  • Fewer adverse effects compared to other modalities
  • Better treatment retention rates
  • Comparable effectiveness to methadone 1

Multiple systematic reviews (Cochrane, Meader 2010, Amato et al.) consistently demonstrate buprenorphine's superiority, though most data comes from inpatient populations 1.

Common Pitfalls to Avoid

  1. Don't give buprenorphine too early - Must confirm active withdrawal by history, physical exam, and COWS score to avoid precipitated withdrawal due to buprenorphine's high binding affinity 1

  2. Don't rely on benzodiazepines as monotherapy - They treat symptoms but don't address the underlying opioid withdrawal pathophysiology

  3. Don't confuse alcohol withdrawal with opioid withdrawal - The research evidence provided includes alcohol withdrawal studies 3, 4, 5 where benzodiazepines ARE first-line; this is NOT applicable to opioid withdrawal

  4. Special caution with methadone patients - Risk of severe and prolonged precipitated withdrawal when transitioning to buprenorphine; wait >72 hours 1

Practical Ordering Approach

If COWS ≥8:

  1. Buprenorphine 4-8 mg SL (primary treatment)
  2. Lorazepam 1-2 mg PO/IV PRN anxiety (adjunctive, use sparingly)
  3. Antiemetics PRN nausea
  4. Loperamide PRN diarrhea
  5. Clonidine PRN if additional symptom control needed 1

If COWS <8:

  1. Symptomatic management only
  2. Lorazepam 1-2 mg PO PRN anxiety/muscle cramps
  3. Reassess COWS in 1-2 hours 1

The evidence does not support COWS-based lorazepam dosing protocols for opioid withdrawal the way CIWA-Ar guides benzodiazepine dosing for alcohol withdrawal 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.